Back to News
Market Impact: 0.45
Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak Reports
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
Moderna shares closed at $202.63, down 17.57%, after reports of a possible leak of late-stage personalized melanoma vaccine data. Investors are awaiting the planned full Phase 3 presentation; the article provides no further details about the data or the presentation date.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment
MRNA-0.70
More News
- Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
- Moderna shares plunge after leak of partial cancer vaccine data
- Moderna's stock tumbles after reported leak of data for cancer vaccine
- Why Moderna stock plunged despite positive cancer vaccine trail results?
- Moderna Stock Sinks Nearly 20% After Leak of Cancer-Vaccine Data
- Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak Reports